What does CiGuPhar do?

CiGuPhar is a wholesaler in Tubize. Private Limited, started on 11 May 2021, 1 establishment.

What is the address of CiGuPhar?

The registered office of CiGuPhar is located at Rue François Englert 10, 1480 Tubize.

Is CiGuPhar still active?

Yes. According to the CBE (31 October 2026) CiGuPhar is active, legal situation “Normale toestand”, started on 11 May 2021.

Is CiGuPhar registered on Peppol?

Yes, CiGuPhar is registered on the Peppol network with ID 0208:0768329971.

What is the enterprise number of CiGuPhar?

The enterprise number of CiGuPhar is BE0768329971.

When was CiGuPhar founded?

CiGuPhar was founded on 11 May 2021.

Who are the directors of CiGuPhar?

According to the 2025 annual accounts, the directors of CiGuPhar are: Cosmex, Medicazu Consulting & Concept BV.

Is CiGuPhar a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 11 May 2021; 4 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did CiGuPhar make in 2025?

CiGuPhar posted a profit after taxes of € 5,741 in financial year 2025.

What is the revenue of CiGuPhar?

As a small company, CiGuPhar is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 23,972.

CiGuPhar (Private Limited) - Tubize - BE0768329971

Dossier CiGuPhar, printed on 31 October 2026 from databakkes.be/en/0768329971/ciguphar. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Board fully replaced NBB

No director from three years ago is still active according to annual account 2025.

Financials

Financial year 2025

CiGuPhar from Tubize, company number BE0768329971, closed financial year 2025 with a result of € 5,741 after tax. For that financial year CiGuPhar recorded a gross margin of € 23,972 and equity of € 41,683. Compared with financial year 2024, the result moved from € 30,942 to € 5,741. The company is profitable. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 7, 2026.

What it is worth Growing

€ 41,683

▲ 16% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 5,741

▼ 81% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 128,144

▲ 16% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 36,683.

People and assets in 2025

Vehicles and equipment

€ 27,912

▼ 30% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 219,400

▼ 12% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 2,124

▼ 94% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 103,454 Gross margin 2022: € 103,454 First fiscal year in the series	€ 45,856 Gross margin 2023: € 45,856 ▼ 56% vs 2022 (€ 103,454) Unfavourable step	€ 58,869 Gross margin 2024: € 58,869 ▲ 28% vs 2023 (€ 45,856) Favourable step	€ 23,972 Gross margin 2025: € 23,972 ▼ 59% vs 2024 (€ 58,869) Unfavourable step	▼ 59%
Profit after taxes	€ 81,604 Profit after taxes 2022: € 81,604 First fiscal year in the series	€ 24,672 Profit after taxes 2023: € 24,672 ▼ 70% vs 2022 (€ 81,604) Unfavourable step	€ 30,942 Profit after taxes 2024: € 30,942 ▲ 25% vs 2023 (€ 24,672) Favourable step	€ 5,741 Profit after taxes 2025: € 5,741 ▼ 81% vs 2024 (€ 30,942) Unfavourable step	▼ 81%
Equity	€ 86,604 Equity 2022: € 86,604 First fiscal year in the series	€ 111,276 Equity 2023: € 111,276 ▲ 28% vs 2022 (€ 86,604) Favourable step	€ 35,942 Equity 2024: € 35,942 ▼ 68% vs 2023 (€ 111,276) Unfavourable step	€ 41,683 Equity 2025: € 41,683 ▲ 16% vs 2024 (€ 35,942) Favourable step	▲ 16%
Total debts	€ 156,425 Total debts 2022: € 156,425 First fiscal year in the series	€ 311,944 Total debts 2023: € 311,944 ▲ 99% vs 2022 (€ 156,425) Unfavourable step	€ 348,212 Total debts 2024: € 348,212 ▲ 12% vs 2023 (€ 311,944) Unfavourable step	€ 279,974 Total debts 2025: € 279,974 ▼ 20% vs 2024 (€ 348,212) Favourable step	▼ 20%
Cash	€ 138,923 Cash 2022: € 138,923 First fiscal year in the series	€ 121,943 Cash 2023: € 121,943 ▼ 12% vs 2022 (€ 138,923) Unfavourable step	€ 110,068 Cash 2024: € 110,068 ▼ 10% vs 2023 (€ 121,943) Unfavourable step	€ 128,144 Cash 2025: € 128,144 ▲ 16% vs 2024 (€ 110,068) Favourable step	▲ 16%
Retained profit	€ 81,604 Retained profit 2022: € 81,604 First fiscal year in the series	€ 106,276 Retained profit 2023: € 106,276 ▲ 30% vs 2022 (€ 81,604) Favourable step	€ 30,942 Retained profit 2024: € 30,942 ▼ 71% vs 2023 (€ 106,276) Unfavourable step	€ 36,683 Retained profit 2025: € 36,683 ▲ 19% vs 2024 (€ 30,942) Favourable step	▲ 19%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 106,276 Dividend 2024: € 106,276 Unchanged (€ 0) Unchanged	€ 0 Dividend 2025: € 0 ▼ 100% vs 2024 (€ 106,276) Unchanged	▼ 100%
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 24,486 Bank debt 2023: € 24,486 Unchanged (€ 0) Unfavourable step	€ 14,682 Bank debt 2024: € 14,682 ▼ 40% vs 2023 (€ 24,486) Favourable step	€ 0 Bank debt 2025: € 0 ▼ 100% vs 2024 (€ 14,682) Favourable step	▼ 100%
Balance sheet total	€ 243,029 Balance sheet total 2022: € 243,029 First fiscal year in the series	€ 423,219 Balance sheet total 2023: € 423,219 ▲ 74% vs 2022 (€ 243,029) Unchanged	€ 384,154 Balance sheet total 2024: € 384,154 ▼ 9% vs 2023 (€ 423,219) Unchanged	€ 321,657 Balance sheet total 2025: € 321,657 ▼ 16% vs 2024 (€ 384,154) Unchanged	▼ 16%

Key figures of CiGuPhar, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to CiGuPhar?

What happened at CiGuPhar in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 7, 2026 New annual accounts for financial year 2025: profit of € 5,741 (▼ 81% vs 2024). Source: NBB ↗
2025 Cosmex became a director. NBB
2025 Medicazu Consulting & Concept BV stepped down as director. NBB
May 11, 2021 New establishment in Tubize. KBO
2021 Medicazu Consulting & Concept BV became a director. NBB
May 11, 2021 Start of the company according to the CBE. KBO

In short

From € 81,604 profit in 2022 to € 5,741 profit in 2025.

Paid € 39,234 in corporate taxes since 2022.

Best year ever: 2022, with € 81,604 profit.

Paid out € 106,276 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

COSMEX 100%

The stake of COSMEX comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

CiGuPhar

Behind CiGuPhar is Cosmex. The shares are held by COSMEX (100%).

Directors

According to the 2025 annual accounts

Cosmex

Director · represented by Sebastiaan Favoreel

since 2025

Medicazu Consulting & Concept BV

Director

Also active at: COSMEX

since 2021 · until 2025

Shareholders

COSMEX

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Rue François Englert 10

1480 Tubize

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 4 companies are registered at this address.

All companies at this address →

IC PHARMA

€ 434,555 gross margin · 2025

INTERCONCEPT

€ 439,282 gross margin · 2025

COSMEX same network

€ 1.1 million gross margin · 2024

IC Store

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0768.329.971

VAT number

BE 0768.329.971

Registered office

Rue François Englert 10, 1480 Tubize

Names & denominations

CiGuPhar

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

11 May 2021

Peppol

Active · Active since 6 Jan 2026

Activities · NACE

Groothandel in parfumerieën en cosmetica

Handelsbemiddeling in de groothandel in meubelen, huishoudelijke artikelen en ijzerwaren

View on CBE Public ↗ Annual accounts (NBB) ↗

CiGuPhar

Warning lights

Financials

What happened to CiGuPhar?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions